Cite
Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)
MLA
Geir Selbæk, et al. Tolerability of Buprenorphine Transdermal System in Nursing Home Patients with Advanced Dementia: A Randomized, Placebo-Controlled Trial (DEP.PAIN.DEM). May 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....97592625b46d1620def7018e6be8c5a4&authtype=sso&custid=ns315887.
APA
Geir Selbæk, Bettina S. Husebo, Elisabeth Flo, Ane Erdal, Dag Aarsland, Dagrun D. Slettebo, & Clive Ballard. (2018). Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM).
Chicago
Geir Selbæk, Bettina S. Husebo, Elisabeth Flo, Ane Erdal, Dag Aarsland, Dagrun D. Slettebo, and Clive Ballard. 2018. “Tolerability of Buprenorphine Transdermal System in Nursing Home Patients with Advanced Dementia: A Randomized, Placebo-Controlled Trial (DEP.PAIN.DEM),” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....97592625b46d1620def7018e6be8c5a4&authtype=sso&custid=ns315887.